HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

Posted on March 2, 2019 by Gastroenterology Journal

Epigenetic reprogramming drives HCV liver cancer risk following DAA cure.

This entry was posted in News. Bookmark the permalink.